Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Correction: Blood pressure: at what level is treatment worthwhile [Correction]

    Australian Prescriber Date published:

  • P6272First plus recurrent CV and hospitalization events in the CArdiovascular and Renal Microvascular outcomE study with LINAgliptin (CARMELINA) in patients with type 2 diabetes and cardiorenal disease

    European Heart Journal Date published:

  • Effect of Canagliflozin on Renal and Cardiovascular Outcomes across Different Levels of Albuminuria: Data from the CANVAS Program

    Journal of the American Society of Nephrology Date published:

  • Canagliflozin and Renal Outcomes in Diabetic Nephropathy

    New England Journal of Medicine Date published:

  • Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME® trial

    Nephrology Dialysis Transplantation Date published:

  • Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

    Circulation Date published:

  • Canagliflozin and fracture risk in individuals with type 2 diabetes: results from the CANVAS Program

    Diabetologia Date published:

  • Blood pressure: at what level is treatment worthwhile?

    Australian Prescriber Date published:

  • Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease

    Annals of Internal Medicine Date published:

  • The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study

    Diabetologia Date published:

  • Effect of extended hours dialysis on markers of chronic kidney disease-mineral and bone disorder in the ACTIVE Dialysis study

    BMC Nephrology Date published:

  • GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Meta-Analysis of Treatment Effects of Randomized Controlled Trials

    Journal of the American Society of Nephrology Date published:

  • Dietary Sodium Reduction Reduces Albuminuria: A Cluster Randomized Trial

    Journal of Renal Nutrition Date published:

  • SAT-298 EFFECT OF SGLT2 INHIBITORS ON CARDIOVASCULAR, RENAL AND SAFETY OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE

    Kidney International Reports Date published:

  • SAT-041 A META-ANALYSIS OF THE REPRESENTATIVENESS OF RANDOMIZED CONTROLLED TRIAL COHORTS IN END-STAGE KIDNEY DISEASE

    Kidney International Reports Date published:

  • SAT-287 eGFR SLOPE AND THE SUBSEQUENT RISK OF CLINICAL OUTCOMES IN TYPE 2 DIABETES

    Kidney International Reports Date published: